The Food and Drug Administration (FDA) has issued draft guidance to facilitate the development of treatments for substance use disorders related to stimulants like cocaine and methamphetamine. The FDA’s draft guidance lays out the agency’s recommendations on the development of clinical trials for drugs aimed at treating moderate to severe cocaine use disorder, methamphetamine use…
Washington Medical Commission fines physician $15,000 for prescribing ivermectin to COVID-19 patients without FDA approval and spreading misinformation.